Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of the Novel HIF-PH Inhibitor Enarodustat: An Open-Label Phase I Study in Healthy Chinese Participants. - Cui C; Niu X; Li H; Zhang R; Geng L; Lin W; Liu Z; Wang X; Liu D (Clinical drug investigation, 2025)